High-dose intravenous pamidronate for metastatic bone pain
- 1 September 1994
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 70 (3) , 554-558
- https://doi.org/10.1038/bjc.1994.344
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Palliative pamidronate treatment in patients with bone metastases from breast cancer.Journal of Clinical Oncology, 1993
- Osteoclast inhibition for the treatment of bone metastasesCancer Treatment Reviews, 1993
- Osteoclast inhibition by pamidronate in metastatic prostate cancer: a preliminary studyBritish Journal of Cancer, 1991
- PamidronateDrugs, 1991
- Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom ChecklistBritish Journal of Cancer, 1990
- Treatment of bone metastases from breast cancer with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD)British Journal of Cancer, 1988
- Sclerosis of lytic bone metastases after disodium aminohydroxypropylidene bisphosphonate (APD) in patients with breast carcinoma.BMJ, 1988
- Dose/response study of aminohydroxypropylidene bisphosphonate in tumor-associated hypercalcemiaThe American Journal of Medicine, 1987
- COMPARISON OF AMINOHYDROXYPROPYLIDENE DIPHOSPHONATE, MITHRAMYCIN, AND CORTICOSTEROIDSICALCITONIN IN TREATMENT OF CANCER-ASSOCIATED HYPERCALCAEMIAThe Lancet, 1985
- Oswestry Low Back Pain Disability QuestionnairePublished by American Psychological Association (APA) ,1980